PTPN9 regulates HER3 phosphorylation during trastuzumab treatment and loss of PTPN9 is a potential biomarker for trastuzumab resistance in HER2 positive breast cancer
Guardat en:
| Autors principals: | , , , , , , , , , , , , , , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Wiley
2025-01-01
|
| Col·lecció: | Cancer Communications |
| Accés en línia: | https://doi.org/10.1002/cac2.12632 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|